Vanguard Medica shares fall

Vanguard Medica shares fall

SHARES IN Vanguard Medica fell 10p to 320p after it said it intended to stop developing two psoriasis treatments, the compounds, VML 295 and VML 262. Vanguard said its decision followed a re-evaluation of the commercial potential of these compounds on completion of phase two studies.

Comments